Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senate Cmte. Shuffle Brings Importation Advocate Specter To Judiciary

Executive Summary

Two key Senate committees for the pharmaceutical industry will have new chairmen in the 109 Congress, and both of them favor importation

You may also be interested in...



Senate Health Committee Adds Republican Sens. Burr, Hatch

Sen.-elect Richard Burr (R-N.C.) will bring a long history of involvement in prescription drug issues to the Senate Health Committee in the 109th Congress

Senate Health Committee Adds Republican Sens. Burr, Hatch

Sen.-elect Richard Burr (R-N.C.) will bring a long history of involvement in prescription drug issues to the Senate Health Committee in the 109th Congress

Senate Health Cmte. Drug Safety Focus Will Be Antidepressants, Not Vioxx

The Senate Health Committee's oversight of FDA's drug safety regulation is likely to focus on the agency's handling of antidepressants

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS045043

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel